14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 61 days ( 0 % )
Last Price $0.108 0 %
High/ Low $0.108 - $0.108 0%
Chg 7 Days N/A $0.108 $0.108
Chg 30 Days N/A $0.108 $0.108
Chg 12 mos -98.99 % $10.67 $0.108
Trend - 3 mos N/A Width: 0.00000000 %
Trend - 12 mos -75.18 % Width: 173.30 %
Pred. range - 3 mos $0.108 - $0.108 0 % - 0 %
Pred. range - 12 mos N/A - $1.20 -100.00 % - 1,014.78 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short/Long MA avg 3 mos Sell Nov 30, -1 - N/A days
Short MA avg 12 mos Sell Jan 11, 2023 - 70 days
Long MA avg 12 mos Sell Oct 21, 2022 - 125 days
Short/Long MA avg 12 mos Sell Oct 24, 2022 - 124 days
Pivot Short Buy Apr 20, 2023 - 2 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Tricida Inc

Tricida Tricida, Inc. operates as a pharmaceutical company. It focuses on the development and commercialization of veverimer (TRC101), a non-absorbed orally-administered polymer that has completed Phase III trial to treat metabolic acidosis in patients with chronic kidney disease by binding and removing acid from the gastrointestinal track. The company was incorporated in 2013 and is headquartered in South San Francisco, California.... TCDA Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT